Presentation on diclofenac
-
Upload
lovnish-thakur -
Category
Education
-
view
334 -
download
0
Transcript of Presentation on diclofenac
![Page 1: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/1.jpg)
Diclofenac- A Common Painkiller
By-Lovnish ThakurASU2014010100099INTEGRATED BIOTECH-4TH SEMBSBT-204(PHARMACEUTICAL SCIENCE)
![Page 2: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/2.jpg)
Introduction
Diclofenac Sodium is NSAID, a phenyl acetic acid derivative
www.newdruginfo.com
NSAIDNon Steroidal
Anti Inflammatory
Drug
![Page 3: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/3.jpg)
General Information
Name- Diclofenac Sodium Chemical Formula- C14H10Cl2NO2.Na Average Molecular Weight- 318.1Drug Category • Anti-Inflammatory Agents, Non-Steroidal • Inhibits cyclooxygenase-1 (COX-1) and COX-2s • Non steroidal Anti-inflammatory Agents
(NSAIDs)
![Page 4: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/4.jpg)
Pharmacokinetics Profile
•Absorption•Distribution •Elimination
![Page 5: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/5.jpg)
Absorption
Bioavailability:
• well absorbed • undergoes first-pass metabolism; only 50–60% of a dose reaches systemic circulation
as unchanged drug. • Peak plasma concentration usually attained within about 1 hour
• Onset: Single 50- or 100-mg doses of diclofenac potassium provide pain relief within 30 minutes.
• Duration: Pain relief lasts up to 8 hours following administration of single 50- or 100-mg doses of diclofenac sodium.
• Food: Food delays time to reach peak plasma concentration but do not affect extent of absorption following administration as conventional, delayed-release, or extended-release tablets.
![Page 6: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/6.jpg)
Distribution
• Extent: Following oral administration, concentrations in synovial fluid may exceed those in plasma.
• Plasma Protein Binding: >99%
![Page 7: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/7.jpg)
Elimination
• Metabolism: Metabolized in the liver via hydroxylation and
conjugation. Some metabolites may exhibit anti-inflammatory activity.
• Elimination Route: Excreted in urine (65%) and in feces via biliary elimination (35%) as metabolites
Half-life: • Oral preparations: 1–2 hours. • Diclofenac epolamine transdermal system: approximately 12
hours
![Page 8: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/8.jpg)
Pharmacodynamic Profile
PharmacologyMechanism of Action
Adverse Reactions
![Page 9: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/9.jpg)
Pharmacology
• Diclofenac has analgesic, antipyretic and anti-inflammatory activities.
• Its potency against cyclooxygenase-1 (COX-1) and COX-2s is substantially greater than that of several other NSAIDs.
Diclofenac is used to treat pain-:• ocular inflammation• osteoarthritis• rheumatoid arthritis• spondylitis
![Page 10: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/10.jpg)
Mechanism of Action
Action by inhibition of prostaglandin synthesis by inhibition of cyclooxygenase (COX)
Prostaglandin-endoperoxide synthase
(PTGS), also known as cyclooxygenase (COX), is
the key enzyme in prostaglandin biosynthesis
![Page 11: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/11.jpg)
![Page 12: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/12.jpg)
Adverse Effects
Cardiovascular System: congestive heart failure, hypertension, tachycardia, syncope.
Digestive System: dry mouth, esophagitis, gastric/peptic ulcers, gastritis, jaundice.
Nervous System: anxiety, asthenia, confusion, depression, drowsiness, Insomnia, malaise, nervousness, tremors, vertigo.
Respiratory System: asthma, dyspnea.
![Page 13: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/13.jpg)
Available Dosage Forms
• Tablet• Solution• Injections• Gels
![Page 14: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/14.jpg)
Conclusion
Diclofenac is a potent drug for treating pain & Inflammation but it should not be taken
without prescription.
![Page 15: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/15.jpg)
Reference
• Novartis. Voltaren (diclofenac sodium enteric-coated tablets) prescribing information. East Hanover, NJ; 2006 Jan.
• Todd PA, Sorkin EM. Diclofenac sodium: a reappraisal of its pharmacodynamic and pharmacokinetic properties, therapeutic efficacy. Drugs. 1988; 35:244-85. [IDIS 240385] [PubMed 3286213]
• www.drugbank.ca/drugs/DB00586• http://www.accessdata.fda.gov/drugsatfda_docs/
label/2011/021005s013lbl.pdf
![Page 16: Presentation on diclofenac](https://reader036.fdocuments.net/reader036/viewer/2022081604/5876c5a51a28ab6d5a8b5c9b/html5/thumbnails/16.jpg)